Sodium chloride 0.45% Glucose 2.5% infusion 500ml Viaflo bags

Valsts: Lielbritānija

Valoda: angļu

Klimata pārmaiņas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktīvā sastāvdaļa:

Glucose anhydrous; Sodium chloride

Pieejams no:

Baxter Healthcare Ltd

ATĶ kods:

B05BB01

SNN (starptautisko nepatentēto nosaukumu):

Glucose anhydrous; Sodium chloride

Deva:

25mg/1ml ; 4.5mg/1ml

Zāļu forma:

Infusion

Ievadīšanas:

Intravenous

Klase:

No Controlled Drug Status

Receptes veids:

Valid as a prescribable product

Produktu pārskats:

BNF: 09020201

Produkta apraksts

OBJECT 1
SODIUM CHLORIDE 0.45 % W/V AND GLUCOSE 2.5%
W/V SOLUTION FOR INFUSION BP
Summary of Product Characteristics Updated 14-Jul-2016 | Baxter
Healthcare Ltd
1. Name of the medicinal product
Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v Solution for Infusion
BP
2. Qualitative and quantitative composition
Sodium Chloride:
Glucose (as monohydrate):
4.5 g/l (0.45 % w/v)
25.0 g/l (2.5 % w/v)
Each ml contains 25 mg glucose (as monohydrate) and 4.5 mg sodium
chloride.
mmol/l:
Na+
:
77
Cl-:77
mEq/l:
Na+
:
77
Cl-:77
Nutritional value: approximately 420 kJ/l (or 100 kcal/l)
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Solution for infusion.
Clear solution, free from visible particles.
Osmolarity: 293 mOsm/l (approx)
pH: 3.5 to 6.5
4. Clinical particulars
4.1 Therapeutic indications
Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v solution is indicated
for:
- Treatment of dehydration or hypovolaemia in cases where supply of
water, sodium chloride and
carbohydrates is required due to restriction of the intake of fluids
and electrolytes by normal routes.
4.2 Posology and method of administration
The choice of the specific sodium chloride and glucose concentration,
dosage, volume, rate and duration
of administration depends on the age, weight, clinical condition of
the patient and concomitant therapy. It
should be determined by a physician. For patients with electrolyte and
glucose abnormalities and for
paediatric patients, consult a physician experienced in intravenous
fluid therapy. Rapid correction of
hyponatraemia and hypernatraemia is potentially dangerous (risk of
serious neurologic complications).
_ADULTS, OLDER PATIENTS AND ADOLESCENTS (AGE 12 YEARS AND OVER):_
The recommended dosage is 500 ml to 3 L/24h
Administration rate
The infusion rate is usually 40 ml/kg/24h and should not exceed the
patient's glucose oxidation capacities
in order to avoid hyperglycaemia. Therefore the maximum acute
administration rate is 5 mg/kg/min.
_PAEDIATRIC POPULATION_
The dosage varies with weight:
- 0-10